ALLIANCE PHARMACEUTICAL CORP
S-4, EX-23.2, 2000-11-09
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ALLIANCE PHARMACEUTICAL CORP, S-4, EX-23.1, 2000-11-09
Next: DENTAL MEDICAL DIAGNOSTIC SYSTEMS INC, SC 13G/A, 2000-11-09



<PAGE>

                                                                    Exhibit 23.2

               CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

     As independent public accountants, we hereby consent to the use of our
report on Molecular Biosystems, Inc. dated May 10, 2000 and to all references to
our Firm included in this registration statement.

Arthur Andersen LLP

November 6, 2000
San Diego, California


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission